Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glabellar Lines”

151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 151 results

Testing effectiveness (Phase 2)Study completedNCT04996810
What this trial is testing

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00430586
What this trial is testing

Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 191
Early research (Phase 1)Study completedNCT04944953
What this trial is testing

To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 38
Large-scale testing (Phase 3)Active Not RecruitingNCT06583486
What this trial is testing

A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd. 488
Large-scale testing (Phase 3)Study completedNCT05380154
What this trial is testing

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 500
Large-scale testing (Phase 3)Study completedNCT05463965
What this trial is testing

Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Galderma R&D 605
Not applicableStudy completedNCT01391299
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines

Who this might be right for
Facial RhytidesGlabellar Frown Lines
Allergan 175
Large-scale testing (Phase 3)Study completedNCT03216408
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Medy-Tox 504
Post-approval studies (Phase 4)Study completedNCT03687736
What this trial is testing

Subject Satisfaction With AbobutulinumtoxinA Treatment

Who this might be right for
Glabellar Frown Lines
Galderma R&D 120
Large-scale testing (Phase 3)Study completedNCT03960957
What this trial is testing

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 301
Testing effectiveness (Phase 2)Study completedNCT02184988
What this trial is testing

Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 352
Large-scale testing (Phase 3)Study completedNCT00752297
What this trial is testing

Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows

Who this might be right for
Glabellar Rhytides
Mentor Worldwide, LLC 402
Large-scale testing (Phase 3)Study completedNCT01791920
What this trial is testing

To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines

Who this might be right for
Skin Aging
Hugel 262
Testing effectiveness (Phase 2)Study completedNCT05743634
What this trial is testing

A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd. 140
Very early researchUnknownNCT05305768
What this trial is testing

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)Study completedNCT00752258
What this trial is testing

A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows

Who this might be right for
Glabellar Rhytides
Mentor Worldwide, LLC 576
Large-scale testing (Phase 3)UnknownNCT03440671
What this trial is testing

The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Huons Co., Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT05217355
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 50
Testing effectiveness (Phase 2)Study completedNCT02428608
What this trial is testing

Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 570
Not applicableStudy completedNCT07374965
What this trial is testing

A Prospective, Non-Interventional, Single-Centre Study Assessing the Efficacy of a Holistic Upper Face Treatment With Botulinum Neurotoxin A

Who this might be right for
Glabellar LinesForehead LinesCrow's Feet+1 more
Yuvell 20
Load More Results